Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Screening in Obstetrics & Gynecology: Management of Abnormality
Alka Pandey, Navneet Magon
CHAPTER 1:
Maternal Red Blood Cell Group and Antibody Screen
INTRODUCTION
Rh Antigens
OTHER RED CELL ANTIBODIES
Fetomaternal Bleed
Prevention of RhD Alloimmunization with Anti-D Immunoglobulin
CLINICAL CONSIDERATIONS IN AN AT-RISK RHD NEGATIVE PREGNANCY
The Alloimmunized Pregnancy
CHAPTER 2:
Antepartum Assessment of Hemoglobin, Hematocrit and Serum Ferritin
INTRODUCTION
Screening of the General Population for Iron Deficiency is not Recommended13
Signs and Symptoms
Specific Tests or Procedures for Assessing Iron Status
Trial of Iron
SUPPLEMENTATION TO PREVENT ANEMIA
TREATMENT OF ANEMIA
PARENTERAL IRON
BLOOD TRANSFUSION
Indications of Blood Transfusion for Anemia in Pregnancy
DELIVERY CARE
CHAPTER 3:
Asymptomatic Bacteriuria
ASYMPTOMATIC BACTERIURIA DURING PREGNANCY
Urinary Tract Infection
Asymptomatic Bacteriuria
Etiology
Infection
Age Related Demographics
Investigations
Urine Specimen Collection
Urine Culture
Urinalysis
Dipstick Testing
Other Tests
Treatment of Bacteriuria and Cystitis
Behavioral Methods
Antibiotic Therapy
ASYMPTOMATIC BACTERIURIA IN NON-PREGNANT PATIENTS
CHAPTER 4:
Screening for Hepatitis A, B, C and E during Pregnancy
INTRODUCTION
HEPATITIS B VIRUS
HEPATITIS C VIRUS
Indications for HCV Screening in Pregnancy
HEPATITIS E VIRUS
HEPATITIS A VIRUS
CHAPTER 5:
First Trimester Screening for Fetal Aneuploidy
INTRODUCTION
BACKGROUND RISK
NUCHAL TRANSLUCENCY
SERUM BIOCHEMICAL MARKERS
Additional First Trimester Sonographic Markers
REPORTING RISKS
NONINVASIVE PRENATAL TESTING (NIPT)
CONCLUSION
CHAPTER 6:
Genetic Sonogram
DEFINITION AND BACKGROUND
SONOGRAPHIC MARKERS FOR DOWN SYNDROME (TRISOMY 21)
Overview of Markers
Conventional Major Markers
New Major Markers
Minor Markers
SENSITIVITY OF MARKER DETECTION
SIGNIFICANCE OF INDIVIDUAL MARKERS
TRISOMY 18 (EDWARD SYNDROME)
TRISOMY 13 (PATAU SYNDROME)
TURNER SYNDROME (XO)
TRIPLOIDY
CONCLUSION
CHAPTER 7:
Ultrasound Detection of Structural Abnormalities in the First Trimester: Always Detectable 9
INTRODUCTION
HEAD AND BRAIN
Acrania (Fig. 7.1)
Definition
Etiology
Incidence
Prenatal Diagnosis
Prognosis
Recurrence Risk
Holoprosencephaly (Fig. 7.2)
Incidence
Prenatal Diagnosis
Associated Defects
Recurrence risk
Prognosis
Encephalocele (Fig. 7.3)
Definition
Etiology
Incidence
Prenatal Diagnosis
Associations
Genetics
ANTERIOR ABDOMINAL WALL DEFECTS
Physiological Gut Herniation
Exomphalos (Fig. 7.4)
Gastroschisis (Fig. 7.5)
Megacystis (Fig. 7.6)
Body Stalk Anomaly
Iniencephaly (Fig. 7.7)
Missing Limbs (Figs 7.8A and B)
CONCLUSION
CHAPTER 8:
Thrombophilia in Pregnancy
INTRODUCTION
Pregnancy a Prothrombotic State
MECHANISMS OF ADVERSE PREGNANCY OUTCOMES ASSOCIATED WITH THROMBOSIS AND THROMBOPHILIA
Types of Thrombophilia
Thrombophillias and Adverse Pregnancy Outcome
Pregnancy Loss
Placental Abruption
Preeclampsia
Thrombophilia-associated Venous Thromboembolism (VTE)
Screening
Diagnosis
Therapy
CONCLUSIONS
CHAPTER 9:
Gestational Diabetes Mellitus
INTRODUCTION
RELEVANCE IN INDIA
DEFINITION
DIAGNOSTIC CRITERIA
Who to Screen?
When to Screen?
How to Screen?
Diabetes in Pregnancy Study Group of India: Role and Relevance
What to do Finally?
Why and How to Manage GDM?
GLYCEMIC GOALS IN PREGNANCY
MEDICAL NUTRITION THERAPY
Oral Hypoglycemic Agents
Insulin
CONCLUSION
CHAPTER 10:
Fundal Height Measurement
INTRODUCTION
TECHNIQUE OF SYMPHYSIO-FUNDAL HEIGHT MEASUREMENT
DETECTION OF INTRAUTERINE GROWTH RESTRICTION AND SMALL-FOR-GESTATIONAL AGE
TIMING AND FREQUENCY OF SYMPHYSIS FUNDAL HEIGHT MEASUREMENT
PATIENT SELECTION
METHOD OF MEASURING
RECORDING
FURTHER EVALUATION
ESTIMATION OF BIRTH WEIGHT AND GESTATIONAL AGE
CONCLUSION
CHAPTER 11:
Management of Fetal Growth Restriction by Doppler Velocimetry
DEFINITIONS
Fetal Growth Restriction
INTRODUCTION
INDICES FOR UNDERSTANDING FETAL HEMODYNAMICS
CHANGES IN THE VASCULATURE
Changes in the Arterial Circulation
Umbilical Artery
Final Remarks for Umbilical Artery Doppler26
Fetal Cerebral Circulation
Cerebroplacental Ratio
Aortic Doppler
Thoracic Aorta
Changes in Venous Circulation
Umbilical Vein
Changes in the Fetal Heart in FGR
PREDICTION OF PREECLAMPSIA AND FGR
Uterine Artery Doppler Measurement
CONCLUSION
CHAPTER 12:
Fetal Growth Restriction
INTRODUCTION
DEFINITIONS
ETIOLOGY
Maternal
Fetal
Placental
SCREENING
Risk Factors
Clinical Examination
Abdominal Palpation
Symphisiofundal Height (SFH)
Ultrasonography
DIAGNOSIS
MANAGEMENT
SURVEILLANCE
TIMING OF DELIVERY
MODE OF DELIVERY
NEONATAL EFFECTS
LONG TERM EFFECTS
PREVENTION
CHAPTER 13:
Screening for Spontaneous Preterm Labor and Delivery
INTRODUCTION
NUMERICAL SCORING
Risk Factors for Preterm Birth
Demographic
Obstetric
Medical
Infectious Causes
Uterine Causes
Lifestyle Factors
Fetal Causes
BIOCHEMICAL MARKERS
Fibronectin
Monitoring of Uterine Activity
Cervical Assessment
CONCLUSIONS
CHAPTER 14:
Screening for Fetal Hypoxia
INTRODUCTION
ANTEPARTUM ASSESSMENT
Fetal Movement Counting
Method of Fetal Movement Count
Nonstress Test (NST)
Contraction Stress Test
Biophysical Profile
Amniotic Fluid Volume
Doppler Velocimetry
Middle Cerebral Artery
Fetal Veins
INTRAPARTUM FETAL ASSESSMENT
Indications
Noninvasive Evaluation of the Fetal Heart Rate
Category I Tracings
Category III Tracings
Category II Tracings
Labor Admission Test
STAN Fetal Heart Monitor (ST Analysis)
Fetal Electrocardiogram
Fetal Scalp Blood Sampling
pH
Fetal Lactate Concentration
Fetal Pulse Oximetry
CHAPTER 15:
Screening in Menopause
INTRODUCTION
OBESITY
Prevention of Obesity and Insulin Resistance
CARDIOVASCULAR DISEASE
RISK ASSESSMENT TOOLS
Heart Attack Risk Calculator19
Framingham Risk Score
OSTEOPOROSIS AND ARTHRITIS
Evaluation for Osteoporosis
Recommendations for DXA Scan in India
WHO Case Finding Strategy?28
OSTEOARTHRITIS
COGNITIVE DECLINE AND DEMENTIA
Screening for Cognitive Function35
SCREENING FOR CANCERS
Breast Cancer
Colorectal Cancer
Other Cancers
METABOLIC SYNDROME
CONCLUSION
CHAPTER 16:
Screening Tests in Contraceptive Users
SCREENING TESTS IN CONTRACEPTIVE USERS
CHAPTER 17:
Genetic Predisposition to Gynecological and Breast Cancers
INTRODUCTION
Hereditary Breast and Ovarian Cancer (HBOC)
GENETIC COUNSELING
MANAGEMENT OF HBOC SYNDROME
Risk Reduction Surgery
Screening Recommendations
Chemoprevention
REPRODUCTIVE OPTIONS
Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Syndrome
Peutz-Jeghers Syndrome
Cowden Syndrome
Li-Fraumeni Syndrome
CONCLUSION
CHAPTER 18:
Screening for Cervical Cancer
INTRODUCTION
NATURAL HISTORY OF CERVICAL PRECANCER AND CANCER
Transformation Zone of the Cervix Uteri
Preinvasive Diseases of Cervix
Risk Factors of Carcinoma Cervix
Human Papilloma Virus in Pathogenesis of Cervical Cancer
SCREENING TECHNIQUES FOR CERVICAL CANCER
Pap Smear Cytology
Visual Inspection Based Screening Technique
HPV Detection Techniques
CERVICAL CANCER SCREENING GUIDELINES
ROLE OF COLPOSCOPY AND HISTOLOGY IN SCREENING
Steps of Colposcopy
OVERVIEW OF TREATMENT OF CERVICAL PRE-CANCER
Ablative Procedures
Prerequisites for Cryotherapy
Excisional Procedures
OVERVIEW OF MANAGEMENT OF INVASIVE CANCER CERVIX
Staging
TREATMENT
CHAPTER 19:
Screening for Ovarian Cancer
RISK FACTORS FOR OVARIAN CANCER
OVARIAN CANCER RISK TYPES4
WHO SCREENING CRITERIA IN OVARIAN CANCER
EVIDENCE OF BENEFIT OR LACK OF BENEFIT ASSOCIATED WITH DIFFERENT SCREENING MODALITIES
Bimanual Pelvic Examination
Ultrasonography
Other Imaging Modalities
Tumor Markers
Multimodal Screening Approach
Serum Proteomics
Multimarker Assay
Risk of Malignancy Index (RMI)
Menopausal Status
Who should be screened?
RISK OF OVARIAN CANCER SCREENING
DISADVANTAGES OF GENETIC TESTING FOR BREAST CANCER GENES
CONCLUSION
CHAPTER 20:
Screening for Thyroid Disorders in Pregnancy
INTRODUCTION
PATHOPHYSIOLOGY
TSH Trimester–Specific Reference Range
HYPOTHYROIDISM
Subclinical Hypothyroidism
Treatment of Overt and Subclinical Hypothyroidism
THYROID AUTOANTIBODIES IN PREGNANCY
ISOLATED HYPOTHYROXINEMIA
SCREENING FOR THYROID DISORDERS DURING PREGNANCY
HYPERTHYROIDISM
Treatment of Hyperthyroidism
Subclinical Hyperthyroidism
Gestational Transient Thyrotoxicosis
POSTPARTUM THYROIDITIS
CHAPTER 21:
Screening for Hemoglobinopathy
INTRODUCTION
INHERITANCE
INCIDENCE
TYPES OF HEMOGLOBINOPATHIES
Sickle Cell Hemoglobinopathies
Thalassemia
Alpha-Thalassemia
Beta-thalassemia
SCREENING FOR HEMOGLOBINOPATHIES
Indications for Screening
Newborn Screening
Recommendations of Other Groups
Clinical Intervention
Screening Methods
Management
Contraception and Sterilization
CHAPTER 22:
Breast Cancer Screening: Current Status
INTRODUCTION
EPIDEMIOLOGY
RISK FACTORS
STRATEGIES FOR SCREENING
FAMILY HISTORY OF BREAST CANCER
TRADE-OFFS BETWEEN BENEFITS AND HARMS
RECOMMENDATIONS FOR SCREENING BY EXPERT GROUPS
Screening with Mammography
CHAPTER 23:
Peripartum Coagulopathy
PLATELET DISORDERS
Thrombocytopenia
Gestational Thrombocytopenia
Inherited Thrombocytopenias
Immune Thrombocytopenic Purpura
Immune Thrombocytopenia and Pregnancy
Thrombocytosis
Thrombocytosis in Pregnancy
INHERITED COAGULATION DEFECTS
HEMOPHILIAS
Clinical Features
Treatment
VON WILLEBRAND DISEASE (VWD)
Pathogenesis
Clinical Presentation
Pregnancy and vWD
Inheritance
OTHER INHERITED COAGULATION FACTOR DEFICIENCIES
THROMBOPHILIAS
GESTATIONAL HYPERTENSION
ACUTE FATTY LIVER OF PREGNANCY
INTRAUTERINE FETAL DEATH AND DELAYED DELIVERY
Fetal Death in Multifetal Pregnancy
PLACENTAL ABRUPTION
AMNIOTIC FLUID EMBOLISM
SEPSIS SYNDROME
Consumptive Coagulopathy
Coagulation and Fibrinolysis- directed agents
DILUTIONAL COAGULOPATHY
CONCLUSION
CHAPTER 24:
Screening for Postpartum Anemia
INTRODUCTION
DEFINITION
DISEASE LOAD
FUNCTIONAL CONSEQUENCES
WHO SHOULD BE SCREENED
Selective verses Universal Screening
CONCLUSION
INDEX
TOC
Index
×
Chapter Notes
Save
Clear